Testing and Targeted Therapy in Triple Negative Breast Cancer: 2023 West Oncology

Testing and Targeted Therapy in Triple Negative Breast Cancer: 2023 West Oncology

Testing, Treating, and Targeting Triple Negative Breast Cancer | 2023 West Oncology ConferenceПодробнее

Testing, Treating, and Targeting Triple Negative Breast Cancer | 2023 West Oncology Conference

Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology ConferenceПодробнее

Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology Conference

Updates in Metastatic Breast Cancer: 2023 West OncologyПодробнее

Updates in Metastatic Breast Cancer: 2023 West Oncology

Adjuvant Therapy | 2023 Best of Breast ConferenceПодробнее

Adjuvant Therapy | 2023 Best of Breast Conference

Lightning Updates | 2023 Best of Breast ConferenceПодробнее

Lightning Updates | 2023 Best of Breast Conference

2022 West Oncology Conference | Breast Cancers | Early-StageПодробнее

2022 West Oncology Conference | Breast Cancers | Early-Stage

Triple Negative Breast Cancer: Predictive and Prognostic Biomarkers for Neo/Adjuvant TherapyПодробнее

Triple Negative Breast Cancer: Predictive and Prognostic Biomarkers for Neo/Adjuvant Therapy

Актуальное